| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 325 | 2021 |
| VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study M Scartozzi, L Faloppi, G Svegliati Baroni, C Loretelli, F Piscaglia, ... International journal of cancer 135 (5), 1247-1256, 2014 | 144 | 2014 |
| From pseudo-ceRNAs to circ-ceRNAs a tale of cross-talk and competition R Taulli, C Loretelli, PP Pandolfi Nature Structural & Molecular Biology 20 (5), 541, 2013 | 142 | 2013 |
| Intragenic antagonistic roles of protein and circRNA in tumorigenesis J Guarnerio, Y Zhang, G Cheloni, R Panella, J Mae Katon, M Simpson, ... Cell research 29 (8), 628-640, 2019 | 132 | 2019 |
| Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients M Scartozzi, R Giampieri, E Maccaroni, M Del Prete, L Faloppi, ... British journal of cancer 106 (5), 799-804, 2012 | 121 | 2012 |
| The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management L Faloppi, M Scartozzi, M Bianconi, G Svegliati Baroni, P Toniutto, ... BMC cancer 14, 1-8, 2014 | 101 | 2014 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 98 | 2021 |
| VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib M Scartozzi, M Bianconi, L Faloppi, C Loretelli, A Bittoni, M Del Prete, ... British journal of cancer 108 (5), 1126-1132, 2013 | 96 | 2013 |
| Mutations of hMLH1 and hMSH2 in Patients With Suspected Hereditary Nonpolyposis Colorectal Cancer: Correlation With Microsatellite Instability and … M Scartozzi, F Bianchi, S Rosati, E Galizia, A Antolini, C Loretelli, A Piga, ... Journal of clinical oncology 20 (5), 1203-1208, 2002 | 89 | 2002 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 84 | 2022 |
| The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management M Scartozzi, L Faloppi, M Bianconi, R Giampieri, E Maccaroni, A Bittoni, ... PloS one 7 (3), e32653, 2012 | 63 | 2012 |
| PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response C Loretelli, A Abdelsalam, F D’Addio, MB Nasr, E Assi, V Usuelli, ... JCI insight 6 (24), 2021 | 54 | 2021 |
| Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients R Giampieri, M Scartozzi, C Loretelli, F Piva, A Mandolesi, G Lezoche, ... PloS one 8 (9), e72843, 2013 | 46 | 2013 |
| Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional … L Belvederesi, F Bianchi, C Loretelli, D Gagliardini, E Galizia, R Bracci, ... European journal of human genetics 14 (7), 853-859, 2006 | 39 | 2006 |
| Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome L Montefusco, F D’addio, C Loretelli, M Ben Nasr, M Garziano, A Rossi, ... Journal of Endocrinological Investigation, 1-9, 2021 | 34 | 2021 |
| Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report A Casadei Gardini, E Chiadini, L Faloppi, G Marisi, A Delmonte, ... BMC cancer 16, 1-5, 2016 | 34 | 2016 |
| An intronic mutation in MLH1 associated with familial colon and breast cancer F Bianchi, M Raponi, F Piva, A Viel, I Bearzi, E Galizia, R Bracci, ... Familial cancer 10, 27-35, 2011 | 34 | 2011 |
| Indirect and direct effects of SARS-CoV-2 on human pancreatic islets M Ben Nasr, F D’Addio, L Montefusco, V Usuelli, C Loretelli, A Rossi, ... Diabetes 71 (7), 1579-1590, 2022 | 33 | 2022 |
| Cell therapy for type 1 diabetes C Loretelli, E Assi, AJ Seelam, M Ben Nasr, P Fiorina Expert opinion on biological therapy 20 (8), 887-897, 2020 | 32 | 2020 |
| MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system L Belvederesi, F Bianchi, E Galizia, C Loretelli, R Bracci, R Catalani, ... Human mutation 29 (11), E296-E309, 2008 | 32 | 2008 |
stefano cascinuUniversità di Modena e Reggio EmiliaEmail verificata su unimore.it
